Vericel (VCEL) EBT Margin Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 |
| Dec 31, 2025 | -144.00 |
| Sep 30, 2025 | -366.00 |
| Jun 30, 2025 | 4,048.00 |
| Mar 31, 2025 | -382.00 |
| Dec 31, 2024 | 228.00 |
| Sep 30, 2024 | -1,297.00 |
| Jun 30, 2024 | 6,674.00 |
| Mar 31, 2024 | 569.00 |
| Dec 31, 2023 | -324.00 |
| Sep 30, 2023 | -203.00 |
| Jun 30, 2023 | 1,333.00 |
| Mar 31, 2023 | 813.00 |
| Dec 31, 2022 | 407.00 |
| Sep 30, 2022 | 1,347.00 |
| Jun 30, 2022 | -758.00 |
| Mar 31, 2022 | 8,581.00 |
| Dec 31, 2021 | 341.00 |
| Sep 30, 2021 | 4,487.00 |
| Jun 30, 2021 | 2,948.00 |
| Mar 31, 2021 | 475.00 |
| Dec 31, 2020 | 5,954.00 |
| Sep 30, 2020 | 5,430.00 |
| Jun 30, 2020 | -2,470.00 |
| Mar 31, 2020 | 2,440.00 |
| Dec 31, 2019 | 4,005.00 |
| Sep 30, 2019 | 9,445.00 |
| Jun 30, 2019 | 11,662.00 |
| Dec 31, 2018 | 6.15 Mn |
| Jun 30, 2018 | 17.44 Mn |
| Mar 31, 2018 | 8.95 Mn |
| Dec 31, 2017 | 4.01 Mn |
| Mar 31, 2017 | 42.76 Mn |
| Sep 30, 2016 | 8.25 Mn |
| Mar 31, 2016 | 6.93 Mn |